These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 2245691

  • 1. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock.
    Danner RL, Natanson C, Elin RJ, Hosseini JM, Banks S, MacVittie TJ, Parrillo JE.
    Chest; 1990 Dec; 98(6):1480-7. PubMed ID: 2245691
    [Abstract] [Full Text] [Related]

  • 2. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock.
    Natanson C, Danner RL, Elin RJ, Hosseini JM, Peart KW, Banks SM, MacVittie TJ, Walker RI, Parrillo JE.
    J Clin Invest; 1989 Jan; 83(1):243-51. PubMed ID: 2642920
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.
    Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE.
    J Clin Invest; 1986 Jul; 78(1):259-70. PubMed ID: 3722379
    [Abstract] [Full Text] [Related]

  • 7. Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock.
    Freeman BD, Yatsiv I, Natanson C, Solomon MA, Quezado ZM, Danner RL, Banks SM, Hoffman WD.
    J Am Coll Surg; 1995 Mar; 180(3):286-92. PubMed ID: 7874338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cardiocirculatory and metabolic effects of endotoxin challenge after canine resuscitated hemorrhagic shock.
    Horton J.
    J Trauma; 1989 Feb; 29(2):195-202. PubMed ID: 2563778
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Plasma endotoxin concentration in healthy primates and during E. coli-induced shock.
    Wessels BC, Wells MT, Gaffin SL, Brock-Utne JG, Gathiram P, Hinshaw LB.
    Crit Care Med; 1988 Jun; 16(6):601-5. PubMed ID: 3286118
    [Abstract] [Full Text] [Related]

  • 16. A new canine model of endotoxin shock.
    Evans SF, Hinds CJ, Varley JG.
    Br J Pharmacol; 1984 Oct; 83(2):433-42. PubMed ID: 6435710
    [Abstract] [Full Text] [Related]

  • 17. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH, Hess ML.
    Circ Shock; 1984 Oct; 12(3):177-89. PubMed ID: 6325034
    [Abstract] [Full Text] [Related]

  • 18. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
    Quezado ZM, Hoffman WD, Winkelstein JA, Yatsiv I, Koev CA, Cork LC, Elin RJ, Eichacker PQ, Natanson C.
    J Exp Med; 1994 Feb 01; 179(2):569-78. PubMed ID: 8294868
    [Abstract] [Full Text] [Related]

  • 19. Augmented venous return: a model of left ventricular afterload reduction during the course of endotoxin shock.
    Hess ML, Krause SM, Komwatana P, Eaton R, Okabe E.
    Circ Shock; 1981 Feb 01; 8(4):435-50. PubMed ID: 7023737
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.